Neuroone Medical Technologies NMTC
NASDAQ NMTC
$2.23 +0.05 (+2.52%)
At close: Aug 20, 2026 · 1:21 PM UTC

Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024)

Neuroone Medical Technologies' (NMTC) quarterly Amortization of Deferred Charges came in at $192647.0 in Q4 2024, down 63.97% on a QoQ basis from $534661.0 in Q3 2018.

Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024) Analysis & Trends

Neuroone Medical Technologies (NMTC) has 4 years of Amortization of Deferred Charges data on file, last reported at $192647.0 in Q4 2024.

  • Quarterly Amortization of Deferred Charges changed N/A year-over-year to $192647.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $192647.0 (changed N/A YoY) and the FY2025 annual result came in at $192647.0, up 90.12% from the prior year.
  • Amortization of Deferred Charges declined to $192647.0 in Q4 2024, from $534661.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $192647.0 in Q4 2024 to a low of $192647.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 Neuroone Medical Technologies 19.36 Mn 17.31 Mn 1.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 192,647.00
Dec 31, 2024 192,647.00
Sep 30, 2018 534,661.00
Sep 30, 2018 534,661.00
Jun 30, 2018 675,632.00
Jun 30, 2018 675,632.00
Mar 31, 2018 437,524.00
Mar 31, 2018 437,524.00
Sep 30, 2017 284,637.00
Sep 30, 2017 284,637.00
Dec 31, 2016 27,555.00
Dec 31, 2016 27,555.00